SEATTLE, March 6 /PRNewswire-FirstCall/ -- Dendreon Corporation
(Nasdaq: DNDN) will release its fourth quarter financial results on
Thursday, March 13, 2008. Company management will host a conference call at
8:00 a.m. PT; 11:00 a.m. ET to review fiscal year 2007 financial results
and provide 2008 financial guidance. Access to the discussion may be
obtained as follows:
Time: 11:00 AM ET /8:00 AM PT
Date: March 13, 2008
Dial-in: 1-877-548-7901 (domestic) or +1-719-325-4844 (international)
Webcast: http://www.dendreon.com (homepage and investor relations
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-888-203-1112 or +1-719-457-0820 for international callers; the conference ID number is 5074038. The replay will be available from 7:30 pm ET on Thursday, March 13 until 11:59 pm ET on Saturday, March 15. In addition the webcast will be archived for on-demand listening for 30 days at http://www.dendreon.com.
Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has headquarters in Seattle and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.
|SOURCE Dendreon Corporation|
Copyright©2008 PR Newswire.
All rights reserved